drugset / Trial / NCT03926962

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

NCT03926962

Phase 1 Completed 67 enrolled Wockhardt
RandomizedParallel-groupQuadruple-blindOther

Summary

This is a double-blind, randomized, placebo-controlled study, consisting of a single ascending dose (SAD) part and a 2-way crossover food effect (FE) part. Each subject will participate in only one cohort during the study.

Timeline

Start
2013-03-14
Primary completion
2013-06-25
Completion
2013-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Nafithromycin Small molecule 100 mg Oral
Subject Nafithromycin Small molecule 1200 mg Oral

Indications

No indication recorded.